ABSTRACT
PURPOSE: We sought to evaluate the technical feasibility of performing a combined robotically assisted mini-percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy (URS) procedure by a single urologist using the MONARCH Platform, Urology (Johnson & Johnson MedTech, Redwood City, California). MATERIAL AND METHODS: In this prospective, first-in-human clinical trial, 13 patients underwent robotically-assisted PCNL for renal calculi at the University of California-Irvine, Department of Urology. Successful completion of the procedure was assessed as the primary endpoint. Postoperative adverse events were monitored for 30 days following the completion of the procedure. Stone ablation efficiency was evaluated on postoperative day 30 with low-dose 2-3 mm slice CT scans. Patients were classified according to the maximum length of their residual stone fragments as either absolute stone-free (Grade A), < 2 mm remnants (Grade B), or 2.1-4.0 mm remnants (Grade C). RESULTS: The combined robotic mini-PCNL and URS procedure was successfully completed in 12 of 13 procedures. No robotic device-related adverse events occurred. Preoperative stone burden was quantified by both maximum linear measurement (median 32.8 mm) as well as by CT-based volume (median 1645.9 mm3). Using the unique robotically assisted targeting system, percutaneous access was gained directly through the center of the renal papilla in a single pass in all cases. Median operative time was 187 minutes (range: 83-383 minutes). On postoperative day 30, a 98.7% (range: 72.9%-100.0%) volume reduction was achieved, with 5 Grade A (38.5%), 1 Grade B (7.7%), and 2 Grade C (15.4%). Three patients experienced complications (2 grade 1 and one grade 2 Clavien-Dindo). CONCLUSIONS: Our preliminary investigation demonstrates the safety, efficacy, and feasibility of a unique robotic-assisted combined mini-PCNL and URS platform.
Subject(s)
Feasibility Studies , Kidney Calculi , Nephrolithotomy, Percutaneous , Robotic Surgical Procedures , Ureteroscopy , Humans , Ureteroscopy/methods , Ureteroscopy/instrumentation , Prospective Studies , Nephrolithotomy, Percutaneous/methods , Nephrolithotomy, Percutaneous/instrumentation , Male , Kidney Calculi/surgery , Middle Aged , Female , Robotic Surgical Procedures/methods , Adult , Lithotripsy/methods , Lithotripsy/instrumentation , Aged , Ureteroscopes , Equipment Design , Treatment OutcomeABSTRACT
PURPOSE: Many major guidelines across the globe address the medical and surgical management of urolithiasis. We elected to compare and contrast the recommendations among the 5 most highly cited guidelines on stone disease to offer insights on where evidence has created a consensus and where there remains ongoing controversy and hence a need for the pursuit of studies that will provide a higher level of evidence. MATERIALS AND METHODS: We reviewed the American Urological Association 2019 medical and 2016 surgical guidelines, the 2016 Canadian Urological Association guidelines, the 2020 European Association of Urology guidelines, the 2019 National Institute for Health and Care Excellence and the 2019 Urological Association of Asia guidelines. Tables correlating guideline statements by topic were created, and a comparative analysis was conducted to ascertain consensus and discordance. RESULTS: Comparative analysis of recommendations from the American Urological Association guidelines to the Canadian Urological Association, European Association of Urology, National Institute for Health and Care Excellence guidelines and Urological Association of Asia revealed a high consensus surrounding the medical management of stones. In terms of the surgical management of stones, there is high consensus regarding the treatment of ureteral stones including medical expulsive therapy using alpha blockers, not prestenting for uncomplicated ureteroscopy and employment of either ureteroscopy or shockwave lithotripsy as first line treatment. There is high consensus among the American Urological Association, European Association of Urology, National Institute for Health and Care Excellence and Urological Association of Asia guidelines regarding renal stone treatment. The Canadian Urological Association does not have guidelines on the management of renal stones. Unlike the American Urological Association and National Institute for Health and Care Excellence, the Canadian Urological Association and European Association of Urology make specific recommendations regarding selection of patients for shockwave lithotripsy procedures, including stone density, skin-to-stone distance, treatment rate, acoustic coupling and postshockwave lithotripsy use of medical expulsive therapy. CONCLUSIONS: There are many areas of consensus and only minor areas of conflict among the most up-to-date American Urological Association, Canadian Urological Association, European Association of Urology, National Institute for Health and Care Excellence and Urological Association of Asia guidelines on the medical and surgical management of stone disease. Conflicts among guidelines and areas of low evidence, such as followup imaging strategies and stone surveillance, the use of a ureteral access sheath in ureteroscopy and guidance on the use of miniaturized percutaneous nephrolithotomy, are opportunities for novel, impactful high grade clinical studies.
Subject(s)
Practice Guidelines as Topic , Urolithiasis/diagnosis , Urolithiasis/therapy , HumansABSTRACT
PURPOSE: Ureteral injury is a frequent complication of ureteral access sheath deployment. We sought to define the safe threshold of force for the passage of a ureteral access sheath using a novel ureteral access sheath force sensor. MATERIALS AND METHODS: Ureteral access sheath-force sensor measurements were recorded in 210 renal units. A 16Fr ureteral access sheath was deployed initially based on a prior porcine study. If 6 N was reached, the surgeon was advised to downsize the 16Fr ureteral access sheath. In each case, a post-ureteroscopic lesion scale was recorded. Regression models were used to estimate the impact of adjusted variables on post-ureteroscopic lesion scale grade, 16Fr ureteral access sheath deployment, and peak force. RESULTS: A 16Fr ureteral access sheath was deployed in 127 (61%) renal units with a mean peak force of 5.7 N. Two high-grade ureteral injuries occurred; in both cases >6 N of force was recorded. Post-ureteroscopic lesion scale grade correlated directly with peak insertion force (p <0.01). Bacteriuria within 60 days of the procedure (OR 2.009, p=0.034), combination of preoperative stent plus oral tamsulosin (OR 2.998, p=0.045), and prior ipsilateral stone surgery (OR 2.13, p=0.01) were independent predictors of successful 16Fr ureteral access sheath deployment. Among patients with neither prior ipsilateral stone surgery nor preoperative stent, preoperative tamsulosin facilitated passage of a 16Fr ureteral access sheath (OR 2.750, p=0.034). CONCLUSIONS: Ureteral access sheath associated ureteral injury can be averted by limiting the insertion force to ≤6 N. Prior stone surgery, preoperative indwelling ureteral stent plus oral tamsulosin, and recently treated bacteriuria favored passage of a 16Fr ureteral access sheath. In the naïve, unstented patient, preoperative tamsulosin favored deployment of a 16Fr ureteral access sheath.
Subject(s)
Dilatation/instrumentation , Iatrogenic Disease/prevention & control , Kidney Calculi/therapy , Ureter/injuries , Female , Humans , Male , Middle Aged , Preoperative Care , Prospective Studies , Stents , Tamsulosin/therapeutic use , Ureteroscopy , Urological Agents/therapeutic useABSTRACT
PURPOSE: Xanthogranulomatous pyelonephritis is a destructive bacterial infection typically necessitating nephrectomy. We hypothesized that long-term preoperative antibiotics would facilitate laparoscopic nephrectomy by reducing the renal inflammation. MATERIALS AND METHODS: We reviewed the records of all patients with histologically confirmed xanthogranulomatous pyelonephritis at 3 University of California institutions between 2005 and 2018. Patients were stratified by antibiotic treatment duration and surgical approach. Patients treated with long-term preoperative antibiotics (28 days or more of continuous treatment until surgery) were compared to patients treated with short-term antibiotics (less than 28 days) and those who only received single-dose prophylactic antibiotics before surgery. Patient demographics and operative outcomes were analyzed. Complications were assigned by Clavien-Dindo classification. RESULTS: Among the 61 patients, 51 (84%) were female and mean age was 50 years. There were 21 (34%) open procedures and 40 (66%) laparoscopic procedures. Median duration of antibiotic treatment was 5 days in those who received a short-term treatment and 87 days in those who received long-term treatment. Eleven patients received only prophylactic single-dose antibiotics. Using multivariate analysis among patients undergoing laparoscopic nephrectomy, controlling for preoperative drainage, long-term antibiotics resulted in a 6.5-day shorter length of stay (p=0.023) and less overall as well as milder postoperative complications (p <0.001). CONCLUSIONS: Greater than or equal to 4 weeks of preoperative antibiotics before laparoscopic nephrectomy for xanthogranulomatous pyelonephritis was associated with shorter length of stay and fewer, less severe postoperative complications.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Laparoscopy/methods , Nephrectomy/methods , Pyelonephritis, Xanthogranulomatous/drug therapy , Pyelonephritis, Xanthogranulomatous/surgery , Antibiotic Prophylaxis , California , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Postoperative Complications , Retrospective StudiesABSTRACT
PURPOSE: Computerized tomographic urography is the diagnostic tool of choice for evaluating hematuria. In keeping with the ALARA (As Low As Reasonably Achievable) principle, we evaluated a triple bolus computerized tomography protocol designed to reduce radiation exposure. MATERIALS AND METHODS: Patients with macroscopic or microscopic hematuria were prospectively randomized to conventional computerized tomography (100) or triple bolus computerized tomography (100). The triple bolus computerized tomography protocol entails 2 scans: pre-contrast scan followed by 3 contrast injections at 40 seconds, 60 seconds and 20 minutes prior to the second scan to capture all 3 phases. The conventional computerized tomography protocol requires 4 scans: pre-contrast scan, and 3 post-contrast scans at the corticomedullary, nephrographic and excretory phases. Radiation exposure and the detection of urological pathology were recorded based on radiology reports. RESULTS: There were no differences in patient demographics or body mass index between the 2 groups. Triple bolus computerized tomography exposed patients to 33% less radiation (1,715 vs 1,145 mGy*cm for conventional vs triple bolus computerized tomography; p <0.001). For macroscopic hematuria, the pathology detection rates were 70% for triple bolus and 73% for conventional computerized tomography (p=0.72). For microscopic hematuria, the detection rates were 59% for triple bolus and 50% for conventional computerized tomography (p=0.68). In both groups, the rates of detection of urolithiasis, renal cysts, urological masses, bladder pathology and prostate pathology were no different between triple bolus and conventional computerized tomography. CONCLUSIONS: In both the settings of macroscopic and microscopic hematuria evaluation, triple bolus computerized tomography significantly reduces radiation exposure while providing equivalent detection of genitourinary pathology compared to conventional computerized tomography. The ability to detect upper tract filling defects was not specifically tested.
Subject(s)
Contrast Media/administration & dosage , Hematuria/diagnostic imaging , Radiation Dosage , Tomography, X-Ray Computed/methods , Urography/methods , Urologic Diseases/diagnostic imaging , Adult , Aged , Aged, 80 and over , Clinical Protocols , Female , Hematuria/etiology , Humans , Injections , Male , Middle Aged , Prospective Studies , Urologic Diseases/complicationsABSTRACT
PURPOSE OF REVIEW: The goal of this paper is to evaluate the use of an office-based renal mass biopsy (RMB), whose feasibility could represent a paradigm shift in clinical practice. RECENT FINDINGS: Despite the earlier diagnosis of patients with renal masses, the lack of evidence showing a reduction in cancer-specific mortality warrants an examination in treatment practices. RMB is underutilized when compared to biopsy practice for all other neoplasms in every other solid organ (except testis), and the majority of RMB performed are outsourced to interventional radiologists. Performing an ultrasound-guided, office-based RMB is safe, reproducible, and has a meaningful impact on management decisions. The use of percutaneous RMB in clinical practice is growing, and the use of RMB has meaningful impact on management decisions for renal masses. Incorporating ultrasound-guided biopsy of a renal mass into clinical practice is feasible, and in contemporary practice, the urologist has the skill set to perform the procedure reliably, with low morbidity, and with minimal patient discomfort.
Subject(s)
Kidney Neoplasms , Kidney , Biopsy , Humans , Image-Guided Biopsy , Kidney Neoplasms/surgery , Male , NephrectomyABSTRACT
We present a simple and reliable method to successfully reconcile the average output power and pulse energy of the solid-state Raman yellow lasers. By virtue of the hybrid laser gain of Nd:YAG and Nd:YVO4 in an intracavity frequency-doubled Raman, much higher pumping is allowed and nearly linear polarized fundamental and Stokes waves can be delivered for efficient non-critical phase matching. 7.6 W of yellow output at 588 nm is obtained under incident pump power of 42.0 W at the pulse repetition frequency (PRF) of 110 kHz and the pulse energy reaches 0.41 mJ under the same incident pump power at the PRF of 10 kHz.
ABSTRACT
An analytical model for analyzing multi-channel intracavity spectroscopy technology (ICST) is established based on rate equations of Er-doped fiber laser. With the consideration of the amplified spontaneous emission, how the mode competition influences the iterative process for a stable output is analyzed. From the perspective of iterative times, the sensitivity-enhanced mechanism of the ICST is explained. Moreover, the theoretical modeling is employed to analyze the role that the mode-competition effect plays in switching the sensing channel automatically. It is demonstrated that, owing to the mode-competition effect in the laser cavity, the modulation of the cavity loss can be used to tune the sensing channel automatically. Furthermore, our proposed theoretical modeling is verified using a multi-channel ICST sensing system. It is indicated that the calculated estimates agree well with those data from the experimental absorption spectra. The principle will play a significant role in realizing the multiplexing of ICST.
ABSTRACT
We have designed a general, inexpensive, and versatile method for the synthesis of (1H-benzo[d]imidazol-2-yl)(phenyl)methanone and the formation of C-N bonds via an aromatic aldehyde and o-phenylenediamine. In the presence of N,N-dimethylformamide/sulfur, (1H-benzo[d]imidazol-2-yl)(phenyl)methanone was obtained; however, in the absence of sulfur, quinoxaline was obtained in 1,4-dioxane. A wide range of quinoxalines and (1H-benzo[d]imidazol-2-yl)(phenyl)methanones was obtained under mild conditions.
ABSTRACT
PURPOSE: We compared the effectiveness of targeted prophylaxis to augmented empirical prophylaxis and single agent empirical prophylaxis to prevent sepsis after transrectal prostate biopsy. MATERIALS AND METHODS: We retrospectively reviewed the records of transrectal prostate biopsies performed during 3 years at 13 Southern California Kaiser Permanente® departments of urology. Targeted prophylaxis was guided by rectal culture bacterial susceptibility for use of a single prophylactic antibiotic while for empirical prophylaxis 1 antibiotic (single agent empirical prophylaxis) or multiple antibiotics (augmented empirical prophylaxis) were given according to the usual practice of the urologist. Sepsis was the primary outcome analyzed. RESULTS: We reviewed 15,236 transrectal prostate biopsy cases. Targeted prophylaxis, single agent empirical prophylaxis and augmented empirical prophylaxis were administered in 26%, 58% and 16% of cases, respectively. The overall incidence of post-biopsy sepsis was 0.64%. On multivariable analysis there was no significant difference in the rate of post-biopsy sepsis after targeted prophylaxis compared to empirical prophylaxis (single agent and augmented empirical prophylaxis together) (OR 0.86, 95% CI 0.53-1.41, p = 0.561). However, on subanalysis augmented empirical prophylaxis showed a significantly lower incidence of sepsis than single agent empirical or targeted prophylaxis (OR 0.35, 95% CI 0.16-0.76, p = 0.008). Based on blood and urine cultures 38% of the patients with sepsis after transrectal prostate biopsy had been given the correct prophylactic antibiotic prior to biopsy. On multivariable analysis Asian/Pacific Islander or Hispanic/Latino ethnicity was associated with a higher incidence of harboring fluoroquinolone resistant bacteria on rectal swab cultures. CONCLUSIONS: This large retrospective study showed that augmented empirical prophylaxis was statistically superior to single agent empirical and targeted prophylaxis. Sepsis developed in a significant number of patients despite being given a prophylactic antibiotic to which the sepsis causing bacteria were sensitive.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis/methods , Endoscopic Ultrasound-Guided Fine Needle Aspiration/adverse effects , Postoperative Complications/prevention & control , Prostatic Neoplasms/diagnosis , Sepsis/prevention & control , Aged , Anti-Bacterial Agents/pharmacology , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Feces/microbiology , Humans , Incidence , Male , Microbial Sensitivity Tests , Middle Aged , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Prostate/diagnostic imaging , Prostate/pathology , Prostatic Neoplasms/pathology , Rectum/microbiology , Retrospective Studies , Sepsis/epidemiology , Sepsis/etiology , Treatment OutcomeABSTRACT
We report an actively Q-switched Nd:YVO4/YVO4 intracavity Raman laser at second-Stokes wavelength of 1313.6 nm, which is capable of operating efficiently under pulse repetition frequency higher than 80 kHz. A folded coupled cavity is adopted to optimize the fundamental and the Stokes resonators individually and make full use of the high pump intensity on the Raman crystal. With relatively high output coupling of 82% at 1313 nm, the average output power of 5.16 W at 1313 nm is achieved under the incident pump power of 36.7 W. The cascaded Raman emission at both the first- and second-Stokes wavelength of 1176 and 1313 nm is investigated to discuss the optimization of the second-Stokes generation.
ABSTRACT
We report herein an efficient actively Q-switched Nd:YVO4/YVO4 intracavity Raman laser operating at 1176 nm. Factors such as resonator geometry and pumping scheme are optimized to strengthen the power scalability and the conversion efficiency of the intracavity Raman laser. With a folded coupled cavity adopted to make full use of the high pump intensity on the Raman crystal, the first-order Stokes output of 10.32 W at 1176 nm is achieved under the incident pump power of 39 W and pulse repetition frequency of 160 kHz. The corresponding optical efficiency reaches 26.4%, and even higher efficiency of 27.8% is obtained at lower incident pump of 34.4 W.
ABSTRACT
Here we propose an efficient diode-end-pumped actively Q-switched 1176-nm Nd:YAG/Nd:YVO4 hybrid gain intracavity Raman laser. By virtue of the construction of a coaxial double crystal, the laser not only can operate efficiently at low pulse repetition frequencies (PRFs), thereby realizing relatively high-energy and high-peak-power pulsed output, but also is capable of generating a high average output power at high PRFs. A maximum pulse energy of 0.54 mJ for the 1176-nm Stokes light is achieved at the PRF of 10 kHz, and the maximum average output power up to 9.80 W is obtained at the PRF of 100 kHz, while the incident pump power is 42.0 W.
ABSTRACT
We report herein the enhancement of output power and optical efficiency of a quasi-three-level Nd:YVO4 laser through a double-end polarized pumping scheme, which improves the usually insufficient pump absorption of the short laser gain medium with low doping concentration, and meanwhile alleviates the influence of thermal effect. 17.7 W laser output at 914 nm is obtained under the launched 808-nm pump of 53.0 W, corresponding to an optical efficiency of 33.4%.
ABSTRACT
We report herein an efficient eye-safe Raman laser, which is based upon Nd:YVO4âYVO4 and in-band pumped by a wavelength-locked laser diode array at 878.6 nm. By virtue of mitigated thermal load and improved pump absorption, a maximum average output power of 5.2 W at 1525 nm is obtained under the incident pump power of 30.6 W with the pulse repetition frequency of 140 kHz, corresponding to an optical efficiency of 17.0%.
Subject(s)
Equipment Safety , Eye/radiation effects , Lasers, Semiconductor , Lasers, Solid-State , Equipment Design , HumansABSTRACT
A multisegmented Nd:YVO4 laser operating at 1342 nm that is in-band pumped by a wavelength-locked 878.6 nm laser diode is reported here. We achieve an output power of 12.45 W at 1342 nm for an absorbed pump power of 35.6 W, corresponding to an optical-to-optical efficiency of 34.9% and a slope efficiency of 36.1%. To the best of our knowledge, it is the highest optical-to-optical efficiency of Nd:YVO4 lasers operating at 1342 nm with an output power more than 10 W.
Subject(s)
Infrared Rays , Lasers, Solid-State , Semiconductors , Energy Transfer , Equipment Design , Equipment Failure AnalysisABSTRACT
Rationale and objectives: Radiomic models based on normal-resolution (NR) computed tomography angiography (CTA) images can fail to distinguish between symptomatic and asymptomatic carotid atherosclerotic plaques. This study aimed to explore the effectiveness of a deep learning-based three-dimensional super-resolution (SR) CTA radiomic model for improved identification of symptomatic carotid atherosclerotic plaques. Materials and methods: A total of 193 patients with carotid atherosclerotic plaques were retrospectively enrolled and allocated into either a symptomatic (n = 123) or an asymptomatic (n = 70) groups. SR CTA images were derived from NR CTA images using deep learning-based three-dimensional SR technology. Handcrafted radiomic features were extracted from both the SR and NR CTA images and three risk models were developed based on manually measured quantitative CTA characteristics and NR and SR radiomic features. Model performances were assessed via receiver operating characteristic, calibration, and decision curve analyses. Results: The SR model exhibited the optimal performance (area under the curve [AUC] 0.820, accuracy 0.802, sensitivity 0.854, F1 score 0.847) in the testing cohort, outperforming the other two models. The calibration curve analyses and Hosmer-Lemeshow test demonstrated that the SR model exhibited the best goodness of fit, and decision curve analysis revealed that SR model had the highest clinical value and potential patient benefits. Conclusions: Deep learning-based three-dimensional SR technology could improve the CTA-based radiomic models in identifying symptomatic carotid plaques, potentially providing more accurate and valuable information to guide clinical decision-making to reduce the risk of ischemic stroke.
ABSTRACT
Introduction: Electromotive Drug Administration (EMDA) amplifies drug delivery deep into targeted tissues. We tested, for the first time, the ability of EMDA to deliver methylene blue into the urothelium of the renal pelvis. Materials and Methods: In an anesthetized female pig, both proximal ureters were transected two inches distal to the ureteropelvic junction. An 8F dual lumen catheter and a 5F fenestrated catheter with an indwelling silver wire were inserted into both renal pelvises following which methylene blue (0.1%) was infused at a rate of 5 mL/min for 20 minutes. In one pelvis, a 4 mA positive pulsed electrical current was applied to the silver wire. Results: In contrast to the control pelvis, the EMDA side macroscopically exhibited dense homogeneous staining; microscopy revealed penetration of methylene blue into the urothelium/lamina propria. Conclusion: In the porcine renal pelvis, application of EMDA increased the penetration of a charged molecule into the urothelium/lamina propria.
Subject(s)
Methylene Blue , Silver , Female , Animals , Swine , Kidney PelvisABSTRACT
Purpose: Retrograde intrarenal surgery is the gold-standard treatment for most kidney stones. During ureteroscopy, ureteral access sheath insertion at forces greater than 8.0 Newtons (N) risks high-grade ureteral injury. To monitor force, our institution utilizes a unique, Bluetooth-equipped device (i.e., the University of California-Irvine Force Sensor). Given the unique nature of the force sensor, we sought to develop an inexpensive and accessible force sensor based on Boyle's law and the specific amount of force required to compress an occluded 1.0 mL syringe. Materials and Methods: We evaluated three brands of 1.0 mL syringes. After setting the plunger at 1.0 mL, the syringe was occluded, and the syringe plunger was compressed. The syringe volume was recorded when the applied force on the plunger reached 4.0 N, 6.0 N, and 8.0 N. Multiple trials were performed to assess reliability and reproducibility. A method for applying this clinically was also developed. Results: The precise force thresholds identified for a 1.0 mL Luer-Lok™ Syringe (Becton Dickinson, Franklin Lakes, NJ) were 0.30 mL for 4.00 N, 0.20 mL for 6.00 N, and 0.15 mL for 8.00 N. The 1.0 mL Tuberculin Syringe and 1.0 mL Luer Slip Syringe were less precise, but compression from 1.0 to 0.40 mL, 0.25 mL, and 0.20 mL corresponded to force sensor readings that did not exceed 4.00 N, 6.00 N, and 8.00 N, respectively. Conclusions: Based on volume changes, 4.00 N, 6.00 N, and 8.00 N of force can be reliably and reproducibly achieved using an occluded 1.0 mL syringe.